Speeding up the search for natural medicines
German researchers have developed a technique to speed up the
discovery of medicinal plant compounds, using a combination of
three analysis techniques.
Roche buys its way out of diagnostics trouble
Roche has moved to settle its long-running legal dispute with
USA-based Igen by acquiring the firm in a deal valued at around
$1.4 billion (€1.22bn).
Amersham trims 2003 profit forecast again
Amersham trimmed its 2003 profit forecast by £40 million (€57m), or
4.1 pence per share, after reporting lower sales and pre-tax
profits for the first half of 2003.
CYP450 variant licensed for genotyping
EPIDAUROS Biotechnologie has acquired a non-exclusive licence for
the diagnostic use of one of the most important genetic variants of
the cytochrome P450 2D6 gene.
EU raps states on animal protection
The European Commission sends written warnings to France, Belgium
and the Netherlands for failing to comply with its regulations on
ASINEX gets new contract from J&J
Russia's ASINEX extends its discovery chemistry contract with
J&J for an additional 12-month period; also launches three
targeted compound libraries.
Bio-Rad buoyed by 2Q figures
Bio-Rad Laboratories defies the often-reported turndown in the life
sciences supply industry with a healthy hike in second quarter
sales and profits.
InnaPhase completes Beckman LAO buy
InnaPhase has completed the transaction of Beckman Coulter's
Laboratory Automation Operations (LAO) that was announced in May of
Tecan takes comfort from stronger second quarter
Tecan second-quarter results reveal some signs of recovery after a
torrid first quarter and the departure of former chief executive
Emile Sutcliffe, with diagnostics holding back an improved
performance in biopharma.
Roche in talks to buy Igen?
Roche is said to be considering a purchase of diagnostics company
Igen International after a US appeals court ruling put a slice of
the Swiss group's diagnostics operations in jeopardy.
Genome on a chip from Applied Bio
Applied Biosystems has unveiled a gene expression analysis product
that allows researchers to conduct studies on the entire human
genome using a single microarray.
Novel psychiatric drugs licensed by Abiogen
Italy's Abiogen Pharma has licensed rights to two UK-developed
compounds that seem to work via a completely new mechanism of
action for the treatment of anxiety.
Pharma's focus on growth "unsustainable" says report
The pharmaceutical industry is failing to increase efficiencies in
core areas of its business - such as clinical trials and sales -
because of an enormous pressure from investors to drive revenues,
according to Datamonitor.
PIERIS expands IP in Anticalins
PIERIS has strengthened its patent estate for a new class of
proteins which could represent a more flexible alternative to
Drug delivers double-whammy to diabetes
Scientists at Roche have discovered a new class of drug, called
glucokinase activators, that may be of use in the treatment of
patients with type 2 diabetes.